St. Jude Reference #SJ-06-0013
An animal vaccine composition and method effective in preventing or ameliorating avian influenza virus (“bird flu”) infection is provided. The vaccine contains at least two inactivated viral strains with a combined hemagglutinin total of at least 200 HA/dose.
bird flu, vaccine, H5N1, H5N3
Granted patents or published applications
Granted patents in the US (9,072,701), Hong Kong, Africa (ARIPO) and China; and patents pending in Indonesia, Vietnam, Egypt, and Africa (OAPI).
Related scientific references
Webster, R.G. et al., “The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens”, Virology 351(2): 303-311 (2006).
We are currently seeking nonexclusive licensing opportunities in all fields for the development of this technology. These patent rights are co-owned with Fort Dodge Animal Health, a division of Wyeth. Contact: email@example.com
Contact the Office of Technology Licensing (Phone: 901-595-2342, Fax: 901-595-3148) for more information.